Morphine Tolerance Increased Cannabinoid Catalepsy Without Matching Temperature Enhancement in Mice
A 1987 mouse study found greater cannabinoid-induced catalepsy after morphine tolerance without comparable enhancement of hypothermia. The same drug history could produce hypersensitivity on one endpoint and a different pattern on another.
Several cannabinoid structures were compared
The experiment included delta-8 THC and two epoxyhexahydrocannabinol forms. Prior tolerance to some, but not all, cannabinoid conditions reduced sensitivity to morphine-related cooling. Chemical similarity therefore did not guarantee identical transfer.
The reverse direction was also selective
Morphine-tolerant mice showed partial temperature cross-tolerance to one tested analogue but not the others. At the same time, cataleptogenic effects of all the tested cannabinoids were enhanced. These results should not be condensed into a single statement of reduced cannabinoid sensitivity.
Latent cross-tolerance was an interpretation
The authors discussed a possible latent temperature cross-tolerance. That proposal does not override the directly reported positive and null comparisons or establish a universal mechanism. Catalepsy is also a specific animal movement state, not a direct measure of subjective intoxication.
The study supports considering hypersensitivity alongside tolerance when assessing a later drug challenge. It does not predict how an opioid-tolerant patient responds to cannabis or establish protection from impairment. Endpoint, analogue identity and pretreatment direction are inseparable from its conclusion.
Related: interpreting cannabis tolerance claims.
Research cited
Narimatsu S; Yamamoto I; Watanabe K; Yoshimura H. Change in hypothermia and catalepsy induced by cannabinoids or morphine in mice tolerant to these substances. European journal of pharmacology (1987). doi:10.1016/0014-2999(87)90562-0. Findings discussed from the study abstract.
